tradingkey.logo
tradingkey.logo
Pesquisar

Cibus Inc

CBUS
Adicionar à lista de desejos
1.390USD
-0.030-2.11%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
106.03MValor de mercado
PerdaP/L TTM

Mais detalhes de Cibus Inc Empresa

Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.

Informações de Cibus Inc

Código da empresaCBUS
Nome da EmpresaCibus Inc
Data de listagemJul 20, 2017
CEOBeetham (Peter Ronald)
Número de funcionários157
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 20
Endereço6455 Nancy Ridge Drive
CidadeSAN DIEGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92121
Telefone18584500008
Sitehttps://www.cibus.com/
Código da empresaCBUS
Data de listagemJul 20, 2017
CEOBeetham (Peter Ronald)

Executivos da empresa Cibus Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.96M
--
Mr. Craig Wichner
Mr. Craig Wichner
Director
Director
894.31K
--
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
592.70K
+38.19%
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
139.88K
+27.17%
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
104.94K
+61.70%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
85.47K
-35.32%
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
--
--
Mr. Cornelis (Carlo) Broos
Mr. Cornelis (Carlo) Broos
Chief Financial Officer
Chief Financial Officer
--
--
Mr. August J. Moretti, J.D.
Mr. August J. Moretti, J.D.
Independent Director
Independent Director
--
--
Ms. Kimberly Ann (Kim) Box
Ms. Kimberly Ann (Kim) Box
Director
Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.96M
--
Mr. Craig Wichner
Mr. Craig Wichner
Director
Director
894.31K
--
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
592.70K
+38.19%
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
139.88K
+27.17%
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
104.94K
+61.70%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
85.47K
-35.32%

Perguntas frequentes

Quem são os cinco principais acionistas de Cibus Inc?

Os cinco principais acionistas de Cibus Inc são: Mr. Rory B. Riggs

Quantas instituições possuem ações da Cibus Inc (CBUS)?

Em 2026Q1, 162 instituições possuíam ações da Cibus Inc, com valor de mercado aproximado de 12.20M, representando 16.60% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -2351528.00.